These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3542726)

  • 1. Newer antibiotics: their place in geriatric care. Part II.
    Gleckman RA; Bergman M
    Geriatrics; 1987 Feb; 42(2):61-4, 67, 70. PubMed ID: 3542726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the development of beta-lactam antibiotics.
    Neu HC
    Scand J Infect Dis Suppl; 1984; 42():7-16. PubMed ID: 6597563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic and clinical aspects of beta-lactam antibiotics and beta-lactamases.
    Kotra LP; Mobashery S
    Arch Immunol Ther Exp (Warsz); 1999; 47(4):211-6. PubMed ID: 10483868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expanding spectrum of beta-lactam antibiotics.
    Allan JD; Eliopoulos GM; Moellering RC
    Adv Intern Med; 1986; 31():119-46. PubMed ID: 3511613
    [No Abstract]   [Full Text] [Related]  

  • 5. [The treatment of bacterial infections with the newer antibiotics].
    Schley G; Wenzel H
    Med Klin; 1981 Mar; 76(7):200-7. PubMed ID: 6971983
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of new beta-lactam antibiotics in intraabdominal surgery.
    Kager L; Nord CE
    Scand J Infect Dis Suppl; 1984; 42():143-50. PubMed ID: 6335598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of anaerobic infections: an overview.
    Finegold SM
    Scand J Infect Dis Suppl; 1985; 46():89-95. PubMed ID: 3865355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
    Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 50th anniversary of the discovery of 6-aminopenicillanic acid (6-APA).
    Rolinson GN; Geddes AM
    Int J Antimicrob Agents; 2007 Jan; 29(1):3-8. PubMed ID: 17137753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Choices of new penicillins and cephalosporins in the DRG era.
    Rahal JJ
    Curr Clin Top Infect Dis; 1988; 9():173-84. PubMed ID: 3151760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current state of multidrug-resistant gram-negative bacilli in North America.
    Nicasio AM; Kuti JL; Nicolau DP
    Pharmacotherapy; 2008 Feb; 28(2):235-49. PubMed ID: 18225969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Beta-lactamases with a wide substrate spectrum in gram negative strictly anaerobic rods].
    Rokosz A; Sawicka-Grzelak A; Kot K; Pituch H; Meisel-Mikołajczyk F; Luczak M
    Med Dosw Mikrobiol; 2000; 52(2):129-37. PubMed ID: 11107787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of the newer antibiotics.
    del Busto R
    Henry Ford Hosp Med J; 1984; 32(2):90-8. PubMed ID: 6392210
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of newer broad-spectrum beta-lactam and fluoroquinolone antibiotics in children.
    Bonafede ME; Blumer JL
    Adv Pediatr Infect Dis; 1996; 12():71-108. PubMed ID: 9033976
    [No Abstract]   [Full Text] [Related]  

  • 15. Imipenem/cilastatin: the first carbapenem antibiotic.
    Lyon JA
    Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer antibiotics: their place in geriatric care. Part I.
    Gleckman RA; Bergman MM
    Geriatrics; 1986 Dec; 41(12):51-5. PubMed ID: 3465671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibiotics and chemotherapy--from research to practice. IX. Remarks directed to practitioners on the characteristics of semi-synthetic penicillins and various other recently discovered beta-lactamases].
    Pilloud M
    Schweiz Arch Tierheilkd; 1984 Feb; 126(2):65-81. PubMed ID: 6608788
    [No Abstract]   [Full Text] [Related]  

  • 18. Criteria for selection of antibiotics in empiric therapy of presumed gram negative infection.
    Betts RF
    Ration Drug Ther; 1981 Apr; 15(4):1-5. PubMed ID: 7347853
    [No Abstract]   [Full Text] [Related]  

  • 19. [Beta-lactamases in laboratory and their role in resistance Part I.: Evolution of bacterial resistance mediated by beta-lactamases].
    Bedenić B
    Lijec Vjesn; 2004; 126(11-12):314-24. PubMed ID: 16082890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbapenems: a potent class of antibiotics.
    Nicolau DP
    Expert Opin Pharmacother; 2008 Jan; 9(1):23-37. PubMed ID: 18076336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.